Evidence map›Paper›PMID 28913930›Full record

ArticleMagnetic resonance in medicine2018

Accuracy, repeatability, and interplatform reproducibility of T

Octavia Bane, Stefanie J Hectors, Mathilde Wagner, Lori L Arlinghaus, Madhava P Aryal, Yue Cao, Thomas L Chenevert, Fiona Fennessy, Wei Huang, Nola M Hylton and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Accurate and precise in vivo liver 3D TMagnetic resonance in medicine · 2025
    Article
  15. Review
  16. Repeatability and reproducibility of rapid TImaging neuroscience (Cambridge, Mass.) · 2025
    Article
  17. Article
  18. Article
  19. A signal model for fat-suppressed TNMR in biomedicine · 2025
    Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 1 country.

Octavia BaneTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Stefanie J HectorsTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mathilde WagnerTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lori L ArlinghausVanderbilt University Medical Center, Nashville, Tennessee, USA.
Madhava P AryalDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Yue CaoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Thomas L ChenevertDepartment of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Fiona FennessyDepartment of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Wei HuangAdvanced Imaging Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
Nola M HyltonDepartment of Radiology, University of California-San Francisco, San Francisco, California, USA.
Jayashree Kalpathy-CramerDepartment of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kathryn E KeenanPhysical Measurement Laboratory, National Institute of Standards and Technology, Boulder, Colorado, USA.
Dariya I MalyarenkoDepartment of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Robert V MulkernDepartment of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
David C NewittDepartment of Radiology, University of California-San Francisco, San Francisco, California, USA.
Stephen E RussekPhysical Measurement Laboratory, National Institute of Standards and Technology, Boulder, Colorado, USA.
Karl F StupicPhysical Measurement Laboratory, National Institute of Standards and Technology, Boulder, Colorado, USA.
Alina TudoricaDepartment of Radiology, Oregon Health and Science University, Portland, Oregon, USA.
Lisa J WilmesDepartment of Radiology, University of California-San Francisco, San Francisco, California, USA.
Thomas E YankeelovDepartment of Radiology, University of Texas at Austin, Austin, Texas, USA.
Yi-Fei YenDepartment of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Michael A BossPhysical Measurement Laboratory, National Institute of Standards and Technology, Boulder, Colorado, USA.ORCID 0000-0002-9492-767X
Bachir TaouliTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Icahn School of Medicine at Mount Sinai · USNational Institute of Standards and Technology · USUniversity of Michigan · USUniversity of California, San Francisco · USBrigham and Women's Hospital · USMassachusetts General Hospital · USOregon Health & Science University · USThe University of Texas at Austin · USVanderbilt University Medical Center · US

Funding

TRAINING PROGRAM IN CANCER THERAPYT32CA078207 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI James J Manfredi · 1999 to 2026
$11.6M
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment TrialsR01CA132870 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M., NEWITT, DAVID C · 2008 to 2019
$4.8M
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant TherapyU01CA142565 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KARCZMAR, GREGORY S., NANDA, RITA · 2010 to 2019
$4.5M
Quantitative DW-MRI for Early Breast Cancer Treatment Response AssessmentU01CA166104 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENEVERT, THOMAS L, GALBAN, CRAIG J · 2012 to 2019
$4.1M
Quantitative MRI of Glioblastoma ResponseU01CA154601 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KALPATHY-CRAMER, JAYASHREE · 2011 to 2016
$3.4M
Quantitative Imaging for Assessing Breast Cancer Response to TreatmentU01CA225427 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M. · 2018 to 2022
$3.2M
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer TherapyU01CA154602 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HUANG, WEI, RYAN, CHRISTOPHER WALTER · 2011 to 2015
$2.9M
Quantitative Imaging for Assessing Breast Cancer Response to TreatmentU01CA151235 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HYLTON-WATSON, NOLA M. · 2011 to 2015
$2.8M
Evaluation of HCC Response to Systemic Therapy with Quantitative MRIU01CA172320 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAOULI, BACHIR · 2013 to 2017
$2.6M
Quantitative MRI models of HN Cancers for Physiological Adaption of RTU01CA183848 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CAO, YUE · 2014 to 2019
$2.0M
Quantitiative MRI of prostate cancer as a biomarker and guide for treatmentU01CA151261 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI FENNESSY, FIONA · 2010 to 2014
$1.8M
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCVR01DK087877 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAOULI, BACHIR · 2010 to 2014
$1.8M
NCI NIH HHS R01 CA132870NCI NIH HHS T32 CA078207NCI NIH HHS U01 CA142565NCI NIH HHS U01 CA151235NCI NIH HHS U01 CA151261NCI NIH HHS U01 CA154601NCI NIH HHS U01 CA154602NCI NIH HHS U01 CA166104NCI NIH HHS U01 CA172320NCI NIH HHS U01 CA183848NCI NIH HHS U01 CA225427NIDDK NIH HHS R01 DK087877
6 · The paper itself

Abstract

purposeTo determine the in vitro accuracy, test-retest repeatability, and interplatform reproducibility of T

methodsA T

resultsFor the common IR-SE protocol, accuracy (median error across platforms = 1.4-5.5%) was influenced predominantly by T

conclusionsThe VFA protocols with 2 to 3 flip angles optimized for different applications achieved acceptable balance of extensive spatial coverage, accuracy, and repeatability in T

Indexed as

Magnetic Resonance ImagingPhantoms, ImagingSignal Processing, Computer-AssistedBrainBreastContrast MediaFemaleHumansImage Interpretation, Computer-AssistedMaleNeoplasmsProstateReproducibility of ResultsContrast MediaDCE-MRImulticenterphantomT1 mapping

Identifiers

PMID28913930
PMCPMC5821553
OpenAlexW2755443763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.